[SphingomabTM, an anti-sphingosine 1-phosphate antibody to inhibit hypoxia]

Med Sci (Paris). 2015 Nov;31(11):964-7. doi: 10.1051/medsci/20153111009. Epub 2015 Nov 17.

[Article in French]

Author

Olivier Cuvillier¹

Affiliation

¹ Institut de pharmacologie et de biologie structurale, CNRS UMR 5089, BP 64182, 205, route de Narbonne, 31077 Toulouse Cedex 4, France - Université de Toulouse, UPS, IPBS, Toulouse, France - Équipe labellisée Ligue contre le Cancer

PMID: 26576602
DOI: 10.1051/medsci/20153111009

No abstract available

Publication types

News

MeSH terms

Antibodies / pharmacology
Antibodies / therapeutic use*
Humans
Hypoxia / therapy*
Lysophospholipids / immunology*
Neoplasms / blood supply
Neoplasms / therapy
Neovascularization, Pathologic / therapy
Sphingosine / analogs & derivatives*
Sphingosine / immunology
Tumor Microenvironment / drug effects

Substances

Antibodies
Lysophospholipids
sphingosine 1-phosphate
Sphingosine